Fulvio A.Scorza, Antonio-Carlos G. de Almeida, Ana C.Fiorini, Carla A.Scorza, JosefFinsterer
In 2020, an estimated 596 million people worldwide had distance vision impairment and a further 510 million had uncorrected near vision impairment, which can profoundly affect individuals, families, and society . Currently, the ultimate goal in ophthalmology research is to establish news actions other than medical that may be effective for the treatment of eye diseases. To a similar extent, as nature has provided an unlimited source of biologically-active compounds, scientists have sought resources in fauna and flora to treat certain major eye diseases . Thus, we enjoyed reading the excellent review article developed by Zhao and colleagues who discussed the latest developments in therapeutic quercetin for the treatment of various ophthalmic diseases . Due to various biological activities, such as antioxidant, anti-inflammatory, and anti-fibrosis activities, the authors appropriately discuss the clinical application of quercetin in keratoconus, Graves’ orbitopathy, ocular surface, cataracts, glaucoma, retinoblastoma, and other retinal diseases .
* THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS IS NOT INTENDED TO DIAGNOSE, TREAT CURE OR PREVENT ANY DISEASE.